logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

YH ENT (02306) spent HKD 134,000 on July 18 to repurchase 48,000 shares.

date
21/07/2025
avatar
GMT Eight
Lehua Entertainment (02306) announced that on July 18, 2025, it spent HK$134,000 to repurchase 4.8...
YH ENT (02306) announcement, on July 18, 2025, to spend 134,000 Hong Kong dollars to repurchase 48,000 shares.
Related Articles
China Stock
The essence of broker morning meeting | The dairy industry is expected to reach a turning point in supply and demand in 2026.
US Stock
Oracle Corporation (ORCL.US) has reached a billion-dollar cloud service agreement with Skydance-Paramount (PARA.US).
HK Stock
CARSGEN-B(02171): The summary of the trial results of Soriatinib injection for adjuvant treatment of pancreatic cancer has been accepted for a poster presentation at the 2025 ESMO Annual Congress.
The essence of broker morning meeting | The dairy industry is expected to reach a turning point in supply and demand in 2026.
China Stock
Oracle Corporation (ORCL.US) has reached a billion-dollar cloud service agreement with Skydance-Paramount (PARA.US).
US Stock
CARSGEN-B(02171): The summary of the trial results of Soriatinib injection for adjuvant treatment of pancreatic cancer has been accepted for a poster presentation at the 2025 ESMO Annual Congress.
HK Stock
RECOMMEND
Total Investment of 1.2 Trillion Yuan: Yarlung Zangbo Hydropower Project Commences, Creating Investment Opportunities in Water Conservancy, Power Grid, and Cement Sectors
Total Investment of 1.2 Trillion Yuan: Yarlung Zangbo Hydropower Project Commences, Creating Investment Opportunities in Water Conservancy, Power Grid, and Cement Sectors
icon
21/07/2025
Another Major Order Secured for Humanoid Robots, Setting a Global Record
Another Major Order Secured for Humanoid Robots, Setting a Global Record
icon
21/07/2025
Seven Ministries Jointly Release 11 Measures to Encourage Foreign-Invested Enterprises to Reinvest in China
Seven Ministries Jointly Release 11 Measures to Encourage Foreign-Invested Enterprises to Reinvest in China
icon
21/07/2025
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.